Early in his career, Adam worked for Smith Barney as a Financial Consultant. He rose quickly through the ranks and became a 2nd Vice President and an Investment Portfolio Manager. During his time at Smith Barney, he was responsible for marketing the Guided Portfolio Management and Asset Management services, while successfully growing his clients’ portfolios. He had six months to introduce and grow these two services throughout the Southern Florida branches and the Southeastern United States. Within a few months, he had accomplished this and both remain the services of choice for most clients throughout the region and the company today. For this success, he received Smith Barney’s Blue Chip Award.
In 2002, after seven years with Smith Barney, Ivax Pharmaceutical (now TEVA Pharmaceutical) approached him to help launch a newly approved Asthma drug, ProAir. Blair succeeded in this endeavor as well, allowing him to rise quickly within Ivax Pharmaceutical. In 2006, Novartis’ Biotech division recruited Blair to become a Xolair Product Specialist. During Blair’s career there, he outpaced his colleagues in the marketing, promotion and sales of Xolair, Novartis and Genentech’s highly acclaimed and most popular asthmatic biotech drug on the market today. And in 2010, Blair established a consulting firm that developed strategic messaging for companies. He created marketing platforms and advertising campaigns for clients in the casino and gaming industry, radiation treatment therapy and medical space.Based on his overall professional achievements, the President of The Performance Institute, Mark Panciera, approached Adam to join the firm. He now works closely with Mark in developing new business, and implementing sales and marketing strategies.
Blair is a graduate of the University of South Florida with a Bachelor of Science degree in Business Marketing.
No comments:
Post a Comment